Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02008006
What this trial is testing

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

Who this might be right for
Follicular Lymphoma
Centre Leon Berard 21
Large-scale testing (Phase 3)Study completedNCT00218855
What this trial is testing

Thalidomide to Patients With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Norwegian University of Science and Technology 363
Testing effectiveness (Phase 2)Study completedNCT01323517
What this trial is testing

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 26
Not applicableEnded earlyNCT00602147
What this trial is testing

Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan

Who this might be right for
MucositisMultiple Myeloma and Plasma Cell Neoplasm
Vanderbilt-Ingram Cancer Center 95
Early research (Phase 1)Active Not RecruitingNCT05139004
What this trial is testing

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT03159702
What this trial is testing

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Who this might be right for
Hematological MalignancyMultiple Myeloma
Medical College of Wisconsin 43
Early research (Phase 1)WithdrawnNCT03506802
What this trial is testing

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
HLA-A*0201 Positive Cells PresentNY-ESO-1 Positive Tumor Cells PresentRecurrent Plasma Cell Myeloma+1 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT02489500
What this trial is testing

Trial of High Dose Melphalan/Stem Cell Transplant With or Without Bortezomib

Who this might be right for
AL Amyloidosis
Boston Medical Center 3
Not applicableUnknownNCT01920516
What this trial is testing

Isolated Limb Perfusion of Melphalan for Melanoma and Sarcoma Treatment

Who this might be right for
Metastatic Melanoma
International Group of Endovascular Oncology 40
Testing effectiveness (Phase 2)Ended earlyNCT02756728
What this trial is testing

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
BioInvent International AB 5
Large-scale testing (Phase 3)Study completedNCT01091831
What this trial is testing

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 389
Testing effectiveness (Phase 2)Study completedNCT00790647
What this trial is testing

Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Boston Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT00804947
What this trial is testing

Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen

Who this might be right for
Multiple Myeloma
Fundacion Para La Investigacion Hospital La Fe 50
Early research (Phase 1)Active Not RecruitingNCT05540340
What this trial is testing

Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Who this might be right for
LymphomaLymphoma, B-CellLymphoma, T-Cell+2 more
Memorial Sloan Kettering Cancer Center 39
Not applicableStudy completedNCT00118339
What this trial is testing

Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Neoplasm
Fred Hutchinson Cancer Center 41
Early research (Phase 1)Study completedNCT01213732
What this trial is testing

Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma

Who this might be right for
Patients With Intransit Stage III/IV Melanoma
Philogen S.p.A. 19
Early research (Phase 1)Study completedNCT00001587
What this trial is testing

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Who this might be right for
Liver NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00002630
What this trial is testing

High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 50
Testing effectiveness (Phase 2)Study completedNCT01160107
What this trial is testing

Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 46
Testing effectiveness (Phase 2)Looking for participantsNCT06679829
What this trial is testing

Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 215
Next Page